Loading
NASDAQHealthcareMedical - Devices
Latest quote
$85.88
+$0.41 · +0.48%
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Previous close
$85.88
+$0.41 · +0.48%
Pre-market
$85.91
+$0.03 · +0.03%
Oct 9, 8:55 AM ET
Regular session · ET · Market data may be delayed.
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Day range
Current $85.88
52-week range
Current $85.88
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
40
Expensive
Sentiment
39
Bearish
Risk
29
Moderate Risk
Momentum
52
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Day range
Current $85.88
52-week range
Current $85.88
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83.81M USD | 73.24M USD | 65.56M USD | 53.3M USD | 41.81M USD |
| Cost of goods sold | 19.49M USD | 16.89M USD | 15.4M USD | 12.02M USD | 9.76M USD |
| Gross profit | 64.32M USD | 56.35M USD | 50.16M USD | 41.28M USD | 32.05M USD |
| Research and development | 2.98M USD | 2.83M USD | 2.86M USD | 2.28M USD | 1.91M USD |
| Selling, general, and administrative | 35.2M USD | 31.55M USD | 27.26M USD | 23.38M USD | 20.33M USD |
| Operating expenses | 38.18M USD | 34.39M USD | 30.12M USD | 25.65M USD | 22.23M USD |
| Interest income | — | 2.19M USD | 1.86M USD | 581.85K USD | 34.81K USD |
| Depreciation and amortization | 1.17M USD | 817.66K USD | 765.18K USD | 670.67K USD | 1.41M USD |
| Operating income | 26.15M USD | 21.96M USD | 20.04M USD | 15.63M USD | 9.82M USD |
| Net income | 22.48M USD | 19.23M USD | 17.19M USD | 12.83M USD | 9.33M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$100
16.44% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI22.84M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM18.31M0.02%77.7B USD0.19%$277.57-0.05%
Dimensional - US Small Cap ETFDFAS8.4M0.02%33.8B USD0.31%$78.10+0.23%
Vanguard Extended Market ETFVXF8.05M0.01%95.4B USD0.05%$233.13-0.15%
iShares Russell 2000 Growth ETFIWO6.88M0.05%14.04B USD0.24%$353.47-0.53%
Vanguard Russell 2000 ETFVTWO4.22M0.02%18B USD0.06%$112.1-0.10%
Schwab U.S. Small-Cap ETFSCHA3.79M0.02%21.73B USD0.03%$32.66+0.15%
U.S. Micro Cap Portfolio ETFDFMC3.79M0.05%7.54B USD0.43%$57.70+0.35%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMDimensional - US Small Cap ETFDFASVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAU.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
